Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Genzyme
BioMarin won't seek control of drug as Sanofi-Genzyme deal closes
BioMarin won't seek control of drug as Sanofi-Genzyme deal closes
Bizjournals.com
Aldurazyme
Biomarin
Genzyme
Sanofi
Genzyme now offically a subsidiary of Sanofi-Aventis
Genzyme now offically a subsidiary of Sanofi-Aventis
Bizjournals.com
Genzyme
Sanofi
News
Protalix Plans Human Clinical Tests of Medication for Rare Fabry's Disease
Bloomberg
Fabrazyme
Fabry's disease
Genzyme
Protalix BioTherapeutics
PRX-102
Replagal
rheumatoid arthritis
Shire
News
Genzyme Fabrazyme shortage to worsen
Bizjournals.com
Fabrazyme
Fabry's disease
Genzyme
News
Pharmas in the Doghouse
Motley Fool
Eli Lilly
Genzyme
JNJ
Merck
Novartis
Pfizer
Sanofi
News
Sanofi Plans Debt to Fund $20.1 Billion Genzyme Purchase
Bloomberg
debt
Genzyme
Sanofi
News
The Genzyme Corporation: Under Pressure for a Lack of Production
Intellectual Property Brief
Fabrazyme
Fabry's disease
Genzyme
patents
News
EMA Says Possible Shortage of Genzyme’s Thyrogen Medicine
Bloomberg
Genzyme
Thyrogen
News
Osiris Profits Rise on Lower Costs
Yahoo/Zacks.com
earnings
Genzyme
Osiris
News
Genzyme’s stock at 1-year high
Bizjournals.com
Genzyme
M&A
Sanofi
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT